S&P 500   4,567.33 (+0.27%)
DOW   35,529.20 (+0.32%)
QQQ   391.32 (+0.29%)
AAPL   189.86 (-0.28%)
MSFT   378.03 (-1.22%)
META   333.59 (-1.59%)
GOOGL   135.61 (-1.16%)
AMZN   146.41 (-0.42%)
TSLA   248.78 (+0.83%)
NVDA   481.54 (+0.70%)
NIO   7.23 (+0.28%)
BABA   74.69 (-2.67%)
AMD   124.48 (+2.02%)
T   16.23 (+0.31%)
F   10.64 (+2.60%)
MU   77.23 (+1.46%)
CGC   0.55 (+1.61%)
GE   119.38 (+0.45%)
DIS   92.68 (+0.19%)
AMC   7.04 (+5.07%)
PFE   30.02 (+1.11%)
PYPL   58.54 (+0.12%)
XOM   103.23 (-0.64%)
S&P 500   4,567.33 (+0.27%)
DOW   35,529.20 (+0.32%)
QQQ   391.32 (+0.29%)
AAPL   189.86 (-0.28%)
MSFT   378.03 (-1.22%)
META   333.59 (-1.59%)
GOOGL   135.61 (-1.16%)
AMZN   146.41 (-0.42%)
TSLA   248.78 (+0.83%)
NVDA   481.54 (+0.70%)
NIO   7.23 (+0.28%)
BABA   74.69 (-2.67%)
AMD   124.48 (+2.02%)
T   16.23 (+0.31%)
F   10.64 (+2.60%)
MU   77.23 (+1.46%)
CGC   0.55 (+1.61%)
GE   119.38 (+0.45%)
DIS   92.68 (+0.19%)
AMC   7.04 (+5.07%)
PFE   30.02 (+1.11%)
PYPL   58.54 (+0.12%)
XOM   103.23 (-0.64%)
S&P 500   4,567.33 (+0.27%)
DOW   35,529.20 (+0.32%)
QQQ   391.32 (+0.29%)
AAPL   189.86 (-0.28%)
MSFT   378.03 (-1.22%)
META   333.59 (-1.59%)
GOOGL   135.61 (-1.16%)
AMZN   146.41 (-0.42%)
TSLA   248.78 (+0.83%)
NVDA   481.54 (+0.70%)
NIO   7.23 (+0.28%)
BABA   74.69 (-2.67%)
AMD   124.48 (+2.02%)
T   16.23 (+0.31%)
F   10.64 (+2.60%)
MU   77.23 (+1.46%)
CGC   0.55 (+1.61%)
GE   119.38 (+0.45%)
DIS   92.68 (+0.19%)
AMC   7.04 (+5.07%)
PFE   30.02 (+1.11%)
PYPL   58.54 (+0.12%)
XOM   103.23 (-0.64%)
S&P 500   4,567.33 (+0.27%)
DOW   35,529.20 (+0.32%)
QQQ   391.32 (+0.29%)
AAPL   189.86 (-0.28%)
MSFT   378.03 (-1.22%)
META   333.59 (-1.59%)
GOOGL   135.61 (-1.16%)
AMZN   146.41 (-0.42%)
TSLA   248.78 (+0.83%)
NVDA   481.54 (+0.70%)
NIO   7.23 (+0.28%)
BABA   74.69 (-2.67%)
AMD   124.48 (+2.02%)
T   16.23 (+0.31%)
F   10.64 (+2.60%)
MU   77.23 (+1.46%)
CGC   0.55 (+1.61%)
GE   119.38 (+0.45%)
DIS   92.68 (+0.19%)
AMC   7.04 (+5.07%)
PFE   30.02 (+1.11%)
PYPL   58.54 (+0.12%)
XOM   103.23 (-0.64%)

Charles & Colvard, Ltd. Stock Price, News & Analysis (NASDAQ:CTHR)

$0.44
-0.01 (-1.53%)
(As of 12:32 PM ET)
Compare
Today's Range
$0.40
$0.46
50-Day Range
$0.30
$0.75
52-Week Range
$0.29
$1.26
Volume
19,512 shs
Average Volume
127,637 shs
Market Capitalization
$13.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Charles & Colvard, Ltd. MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.42% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.97mentions of Charles & Colvard, Ltd. in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$65,824 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.15 out of 5 stars

Consumer Discretionary Sector

146th out of 277 stocks

Jewelry, Silverware, & Plated Ware Industry

2nd out of 2 stocks


CTHR stock logo

About Charles & Colvard, Ltd. Stock (NASDAQ:CTHR)

Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company operates in two segments, Online Channels and Traditional. It manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. The company also markets and distributes lab grown diamonds and finished jewelry with lab grown diamonds under the Caydia brand. It sells its products at wholesale prices to distributors, manufacturers, retailers, and designers; and to end-consumers at retail prices through charlesandcolvard.com and moissaniteoutlet.com, third-party online marketplaces, drop-ship, and other e-commerce outlets, as well as through Charles & Colvard Signature Showroom and charlesandcolvarddirect.com for wholesale and retail customers. Charles & Colvard, Ltd. was incorporated in 1995 and is headquartered in Morrisville, North Carolina.

CTHR Stock Price History

CTHR Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Charles & Colvard Ltd CTHR
Charles Schwab Corp SCHW
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Charles & Colvard Insiders Placed Bullish Bets Worth US$1.8m
CTHR - Charles & Colvard, Ltd.
Charles McNulty
Charles & Colvard (NASDAQ: CTHR)
8-K: CHARLES & COLVARD LTD
Q3 2023 Charles & Colvard Ltd Earnings Call
See More Headlines
Receive CTHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Charles & Colvard, Ltd. and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2023
Today
11/29/2023
Next Earnings (Estimated)
2/01/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Jewelry, silverware, & plated ware
Sub-Industry
N/A
Current Symbol
NASDAQ:CTHR
Employees
48
Year Founded
N/A

Profitability

Net Income
$-19,580,000.00
Pretax Margin
-54.59%

Debt

Sales & Book Value

Annual Sales
$29.95 million
Book Value
$1.23 per share

Miscellaneous

Free Float
24,003,000
Market Cap
$12.75 million
Optionable
Not Optionable
Beta
0.91
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report














CTHR Stock Analysis - Frequently Asked Questions

How have CTHR shares performed in 2023?

Charles & Colvard, Ltd.'s stock was trading at $0.8225 on January 1st, 2023. Since then, CTHR stock has decreased by 49.9% and is now trading at $0.4120.
View the best growth stocks for 2023 here
.

Are investors shorting Charles & Colvard, Ltd.?

Charles & Colvard, Ltd. saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 96,500 shares, a drop of 10.6% from the October 31st total of 107,900 shares. Based on an average daily trading volume, of 245,500 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.4% of the company's stock are sold short.
View Charles & Colvard, Ltd.'s Short Interest
.

When is Charles & Colvard, Ltd.'s next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 1st 2024.
View our CTHR earnings forecast
.

How were Charles & Colvard, Ltd.'s earnings last quarter?

Charles & Colvard, Ltd. (NASDAQ:CTHR) released its quarterly earnings data on Thursday, November, 9th. The company reported ($0.08) earnings per share (EPS) for the quarter. The business earned $4.95 million during the quarter. Charles & Colvard, Ltd. had a negative net margin of 77.13% and a negative trailing twelve-month return on equity of 46.30%.

What other stocks do shareholders of Charles & Colvard, Ltd. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Charles & Colvard, Ltd. investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Golar LNG Partners (GMLP), Novan (NOVN), Organigram (OGI), Pennsylvania Real Estate Investment Trust (PEI), Bionano Genomics (BNGO), Gran Tierra Energy (GTE), Zosano Pharma (ZSAN) and Aeterna Zentaris (AEZS).

Who are Charles & Colvard, Ltd.'s major shareholders?

Charles & Colvard, Ltd.'s stock is owned by a number of institutional and retail investors. Top institutional investors include Punch & Associates Investment Management Inc. (6.07%), Acadian Asset Management LLC (1.47%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Clint J Pete, Don O'connell, Neal I Goldman and Ollin B Sykes.
View institutional ownership trends
.

How do I buy shares of Charles & Colvard, Ltd.?

Shares of CTHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:CTHR) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -